Prevalence and Risk Factors for Complications in Patients with Nontransfusion Dependent Alpha- and Beta-Thalassemia

被引:14
|
作者
Winichakoon, Poramed [1 ]
Tantiworawit, Adisak [1 ]
Rattanathammethee, Thanawat [1 ]
Hantrakool, Sasinee [1 ]
Chai-Adisaksopha, Chatree [1 ]
Rattarittamrong, Ekarat [1 ]
Norasetthada, Lalita [1 ]
Charoenkwan, Pimlak [2 ]
机构
[1] Chiang Mai Univ, Fac Med, Div Hematol, Dept Internal Med, 110 Intravaroros Rd, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Fac Med, Div Hematol & Oncol, Dept Pediat, Chiang Mai 50200, Thailand
关键词
D O I
10.1155/2015/793025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Nontransfusion dependent thalassemia (NTDT) is a milder form of thalassemia that does not require regular transfusion. It is associated with many complications, which differ from that found in transfusion-dependent thalassemia (TDT). Currently available information is mostly derived from beta-NTDT; consequently, more data is needed to describe complications found in the alpha-NTDT form of this disease. Methods. We retrospectively reviewed the medical records of NTDT patients from January 2012 to December 2013. Complications related to thalassemia were reviewed and compared. Results. One hundred patients included 60 females with a median age of 38 years. The majority (54 patients) had alpha-thalassemia. Overall, 83 patients had one or more complications. The three most common complications were cholelithiasis (35%), abnormal liver function (29%), and extramedullary hematopoiesis (EMH) (25%). EMH, cardiomyopathy, cholelithiasis, and pulmonary hypertension were more commonly seen in beta-thalassemia. Osteoporosis was the only complication that was more common in alpha-thalassemia. The risk factors significantly related to EMH were beta-thalassemia type and hemoglobin < 8 g/dL. The risk factors related to osteoporosis were female gender and age > 40 years. Iron overload (ferritin > 800 ng/mL) was the only risk factor for abnormal liver function. Conclusion. The prevalence of alpha-NTDT complications was lower and different from beta-thalassemia.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] ALPHA- AND BETA-THALASSEMIA IN THAILAND
    WASI, P
    NANAKORN, S
    POOTRAKUL, SN
    SOOKANEK, M
    DISTHASONGCHAN, P
    PORNPATKUL, M
    PANICH, V
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1969, 165 (A1) : 60 - +
  • [2] Molecular and Hematological Analysis of Alpha- and Beta-Thalassemia in a Cohort of Mexican Patients
    del Carmen Rizo-de la Torre, Lourdes
    Manuel Renteria-Lopez, Victor
    Yoaly Sanchez-Lopez, Josefina
    Teresa Magana-Torres, Maria
    Ibarra-Cortes, Bertha
    Javier Perea-Diaz, Francisco
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2021, 25 (03) : 247 - 252
  • [3] Burden of Illness of Alpha- and Beta-Thalassemia: A Qualitative Study
    Sheth, Sujit
    Glaros, Alexander K.
    Martin, Mona
    Abel, Cristina
    Lenderking, William R.
    Morris, Susan
    Gilroy, Keely S.
    Kuo, Kevin H. M.
    BLOOD, 2023, 142
  • [4] Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong - Implications for population screening
    Lau, YL
    Chan, LC
    Chan, YYA
    Ha, SY
    Yeung, CY
    Waye, JS
    Chui, DHK
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (18): : 1298 - 1301
  • [5] Common Complications in Beta-Thalassemia Patients
    Yaman, Ayhan
    Isik, Pamir
    Yarali, Nese
    Karademir, Selmin
    Cetinkaya, Semra
    Bay, Ali
    Ozkasap, Serdar
    Kara, Abdurrahman
    Tunc, Bahattin
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2013, 23 (03): : 193 - 199
  • [6] Successful preimplantation genetic diagnosis for alpha- and beta-thalassemia in China
    Jie, Deng
    Wen-Lin, Peng
    Jie, Li
    Cong, Fang
    Xiao-Yan, Liang
    Yan-Hong, Zeng
    Hong-Yu, Sun
    Can-Quan, Zhou
    Guang-Lun, Zhuang
    PRENATAL DIAGNOSIS, 2006, 26 (11) : 1021 - 1028
  • [7] Human leukocyte antigen immunization in transfusion- dependent Moroccan patients with beta-thalassemia major: prevalence and risk factors
    Ouadghiri, Sanae
    El Morabit, Kaoutar
    Elansari, Naoual
    Atouf, Ouafae
    Elkababri, Maria
    Hessissen, Laila
    Essakalli, Malika
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (04) : 360 - 365
  • [8] Red blood cell alloimmunizations in beta-thalassemia patients in Casablanca/Morocco: Prevalence and risk factors
    El Kababi, S.
    Benajiba, M.
    El Khalfi, B.
    Hachim, J.
    Soukri, A.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2019, 26 (04) : 240 - 248
  • [9] Prevalence and Risk Factors of Complications in Patients with Thalassemia Intermedia
    Tantiworawit, Adisak
    Winichakoon, Poramed
    Hantrakool, Sasinee
    Chai-adisaksopha, Chatree
    Rattarittamrong, Ekarat
    Norasetthada, Lalita
    BLOOD, 2014, 124 (21)
  • [10] Clinical complications among patients with transfusion-dependent beta-thalassemia in Germany
    Tuzin, P.
    Udeze, C.
    Kunzweiler, C.
    Li, N.
    Baldwin, J.
    Barth, S. D.
    Vetter, C.
    Dombrowski, S.
    Georgiadou-Schmidt, E.
    Meisel, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 300 - 300